Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ADAMTS9 antisense RNA 2 | 0.656 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 6 | 6 | 2010 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2018 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1524 | 0.839 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2015 | 2019 | |||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2018 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2018 | 2019 | |||||||||
|
MAPT antisense RNA 1 | 0.711 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1415 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | |||||||||||
|
SPRY4 antisense RNA 1 | 0.890 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
C1QTNF7 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
SMIM2 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||||
|
serous ovarian cancer associated RNA | 0.821 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 2657 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
cofilin 1 pseudogene 1 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||||
|
long intergenic non-protein coding RNA 1122 | 0.821 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | |||||||||
|
ZBTB44 divergent transcript |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2018 | 2019 | |||||||||||
|
ZBED3 antisense RNA 1 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
ZBED5 antisense RNA 1 | 0.890 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | |||||||||
|
CCNT2 antisense RNA 1 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
HOXA distal transcript antisense RNA | 0.575 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
SRD5A3 antisense RNA 1 | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
IQCH antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
DPH6 divergent transcript | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
C1QTNF3-AMACR readthrough (NMD candidate) | 0.931 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1505 | 0.821 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
SWI/SNF complex antagonist associated with prostate cancer 1 | 0.751 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |